PEPG: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Research and development expenses	57,192	-
General and administrative expenses	16,715	-
Operating loss	-73,907	-
Interest income	2,598	-
Other income (expense), net	-6	-
Total other income (expense), net	2,592	-
Net loss	-71,315	-53,289
Depreciation	1,061	722
Stock-based compensation expense	8,172	5,795
Amortization and interest accretion related to operating lease	2,811	1,874
Accretion of discounts on marketable securities, net	1,441	1,150
Impairment of long-lived assets	701	701
Other non-cash adjustments	0	0
Prepaids and other current and non-current assets	-1,028	-737
Accounts payable	-971	-885
Accrued expenses and other non-current liabilities	-3,523	496
Operating lease liabilities, current and non-current	-2,313	-1,532
Net cash used in operating activities	-65,790	-46,531
Purchases of property and equipment	265	168
Purchases of marketable securities	6,726	6,726
Maturities of marketable securities	58,000	39,000
Net cash provided by (used in) investing activities	51,009	32,106
Issuance of common stock in public offering, net of underwriters' fees	108,100	0
Payment of offering costs	75	0
Issuance of common stock from atm sales agreement, net of underwriters' fees	0	0
Proceeds from employee equity plans	125	98
Net cash provided by financing activities	108,150	98
Effect of exchange rate changes on cash	-15	-22
Net increase (decrease) in cash, cash equivalents and restricted cash	93,354	-14,349
Cash and cash equivalents at beginning of period	50,969	-
Cash and cash equivalents at end of period	144,323	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

PEPG: the cashflow